Alendronic acid and Cimzia drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Alendronic acid (alendronate sodium) and Cimzia (certolizumab pegol). Common drug interactions include hypersensitivity among females and drug ineffective among males.
The phase IV clinical study analyzes what interactions people have when they take Alendronic acid and Cimzia. It is created by eHealthMe based on reports of 3,394 people who take the same drugs from the FDA, and is updated regularly.
What is Alendronic acid?
Alendronic acid has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 18,408 Alendronic acid users. Check the latest studies of Alendronic acid.
What is Cimzia?
Cimzia has active ingredients of certolizumab pegol. It is often used in rheumatoid arthritis. eHealthMe is studying from 106,745 Cimzia users. Check the latest studies of Cimzia.
3,394 people who take Alendronic acid and Cimzia together, and have interactions are studied.
What are the common drug interactions of Alendronic acid and Cimzia, by gender? *
What are the common drug interactions of Alendronic acid and Cimzia, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Alendronic acid and Cimzia?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Alendronic acid (18,408 reports)
- Cimzia (106,745 reports)
Browse all drug interactions of Alendronic acid and Cimzia:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Alendronic acid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cimzia:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Alendronic acid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cimzia and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
- Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on alendronate sodium and certolizumab pegol (the active ingredients of Alendronic acid and Cimzia, respectively), and Alendronic acid and Cimzia (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Elocon and Modafinil - now
- Oxygen Saturation Decreased and drugs of ingredients of rizatriptan benzoate - 5 seconds ago
- Non-Hodgkin'S Lymphoma and Bicytopenia - 5 seconds ago
- Crohn'S Disease and drugs of ingredients of certolizumab pegol - 11 seconds ago
- Abdominal Pain and drugs of ingredients of terazosin hydrochloride - 28 seconds ago
- Drug interactions of Tegretol and Pantoprazole Sodium - 37 seconds ago
- Drug interactions of Losartan Potassium and Diclofenac - 40 seconds ago
- Drug interactions of Olmesartan Medoxomil and Claritin - 41 seconds ago
- Topamax and Codeine drug interactions for women aged 40-49 - 41 seconds ago
- Thirst - Excessive and drugs of ingredients of orlistat - 48 seconds ago